BI

BVF Inc Portfolio holdings

AUM $2.8B
This Quarter Return
+32.49%
1 Year Return
+17.96%
3 Year Return
+404.14%
5 Year Return
+563.41%
10 Year Return
+5,885.83%
AUM
$588M
AUM Growth
+$588M
Cap. Flow
-$173M
Cap. Flow %
-29.44%
Top 10 Hldgs %
70.6%
Holding
33
New
4
Increased
8
Reduced
8
Closed
3

Top Buys

1
ANAB icon
AnaptysBio
ANAB
$48.2M
2
CTMX icon
CytomX Therapeutics
CTMX
$21.6M
3
BLRX
BioLineRX
BLRX
$16.8M
4
LOXO
Loxo Oncology, Inc
LOXO
$13.5M
5
XOMA icon
Xoma
XOMA
$8.53M

Top Sells

1
CTIC
CTI BioPharma Corp. (DE) Common Stock
CTIC
$169M
2
BPMC
Blueprint Medicines
BPMC
$46.1M
3
ARRY
Array Biopharma Inc
ARRY
$19.9M
4
CLCD
CoLucid Pharmaceuticals, Inc.
CLCD
$17.6M
5
ESPR icon
Esperion Therapeutics
ESPR
$8.92M

Sector Composition

1 Healthcare 75.88%
Name Market Value Portfolio Weight Shares or Principal Shares
Change % 		Capital Flow
BPMC
1
DELISTED
Blueprint Medicines
BPMC
$84.1M 14.3% 2,102,280 -1,153,000 -35% -$46.1M
CCXI
2
DELISTED
ChemoCentryx, Inc.
CCXI
$58.2M 9.89% 7,990,572 +192,000 +2% +$1.4M
CYTK icon
3
Cytokinetics
CYTK
$4.23B
$54.8M 9.31% 4,260,836 -590,855 -12% -$7.59M
ANAB icon
4
AnaptysBio
ANAB
$569M
$48.2M 8.21% +1,738,600 New +$48.2M
CNCE
5
DELISTED
Concert Pharmaceuticals, Inc.
CNCE
$39.9M 6.78% 2,336,609 -279,640 -11% -$4.77M
CTMX icon
6
CytomX Therapeutics
CTMX
$336M
$31.2M 5.3% 1,804,675 +1,249,869 +225% +$21.6M
FWP
7
DELISTED
Forward Pharma A/S American Depositary Shares
FWP
$29.9M 5.09% 1,387,853 – –
INFI
8
DELISTED
Infinity Pharmaceuticals, Inc.
INFI
$25.4M 4.32% 7,866,108 +5,300 +0.1% +$17.1K
ARRY
9
DELISTED
Array Biopharma Inc
ARRY
$24.7M 4.2% 2,763,086 -2,223,100 -45% -$19.9M
CTIC
10
DELISTED
CTI BioPharma Corp. (DE) Common Stock
CTIC
$18.8M 3.2% 4,479,691 -40,317,249 -90% -$169M
BLRX
11
BioLineRX
BLRX
$16.2M
$16.8M 2.86% +17,500,000 New +$16.8M
OMED
12
DELISTED
OncoMed Pharmaceuticals, Inc.
OMED
$16.2M 2.76% 1,760,489 – –
CBIO
13
Crescent Biopharma, Inc. Common Stock
CBIO
$200M
$15.3M 2.61% 2,826,282 – –
ACHN
14
DELISTED
Achillion Pharmaceuticals, Inc.
ACHN
$13.8M 2.35% 3,285,400 +862,100 +36% +$3.63M
LOXO
15
DELISTED
Loxo Oncology, Inc
LOXO
$13.5M 2.29% +320,000 New +$13.5M
CASC
16
DELISTED
Cascadian Therapeutics, Inc.
CASC
$13M 2.21% 3,133,224 – –
XENE icon
17
Xenon Pharmaceuticals
XENE
$2.98B
$11.8M 2.01% 2,949,794 -94,011 -3% -$376K
XOMA icon
18
Xoma
XOMA
$392M
$10.7M 1.82% 1,502,800 +1,200,000 +396% +$8.53M
FATE icon
19
Fate Therapeutics
FATE
$120M
$8.85M 1.51% 1,945,245 -1,814,153 -48% -$8.25M
IMDZ
20
DELISTED
Immune Design Corp.
IMDZ
$8.39M 1.43% 1,233,976 -86,188 -7% -$586K
ARQL
21
DELISTED
Arqule Inc
ARQL
$7.84M 1.33% 7,400,128 – –
VIRX
22
DELISTED
Viracta Therapeutics, Inc. Common Stock
VIRX
$6.32M 1.07% 1,540,323 +147,603 +11% +$605K
ALPN
23
DELISTED
Alpine Immune Sciences, Inc. Common Stock
ALPN
$5.44M 0.93% 1,864,474 – –
ONCT
24
DELISTED
Oncternal Therapeutics, Inc. Common Stock
ONCT
$5.39M 0.92% 1,108,433 – –
PVLA
25
Palvella Therapeutics, Inc. Common Stock
PVLA
$599M
$4.98M 0.85% 1,917,033 +62,265 +3% +$162K
1
2